Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 13, 2017

Glycogen storage disease type IX and growth hormone deficiency presenting as severe ketotic hypoglycemia

Juanita K. Hodax, Serife Uysal, Jose Bernardo Quintos and Chanika Phornphutkul

Abstract

Background:

Glycogen storage disease (GSD) type IX and growth hormone (GH) deficiency cause ketotic hypoglycemia via different mechanisms and are not known to be associated. We describe a patient presenting with severe ketotic hypoglycemia found to have both GSD IX and isolated GH deficiency.

Case presentation:

A 3-year-and-11-month-old boy with a history of prematurity, autism, developmental delay, seizures, and feeding difficulty was admitted for poor weight gain and symptomatic hypoglycemia. He was nondysmorphic, with a height of 93.8 cm (2%, –1.97 SDS), and has no hepatomegaly. He developed symptomatic hypoglycemia, with a serum glucose level of 37 mg/dL after 14 h of fasting challenge. Critical sample showed a GH of 0.24 ng/mL. GH provocative stimulation testing was done with a peak GH of 2.8 ng/mL. Brain magnetic resonance imaging showed a hypoplastic pituitary gland. Given the clinical symptoms, suspicion for mitochondrial disease was high. Dual Genome Panel by Massively Parallel Sequencing revealed a hemizygous variant c.721A>G (p1241V) in the X-linked PHKA2 gene, a causative gene for GSD IX. Red blood cell PhK enzyme activity testing was low, supporting the diagnosis.

Conclusions:

Given the patient’s developmental delays that were not explained by GH deficiency alone, further investigation showed two unrelated conditions resulting in deranged metabolic adaptation to fasting leading to severe hypoglycemia.


Corresponding author: Chanika Phornphutkul, MD, Division of Human Genetics, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, 593 Eddy Street POB 234, Providence, RI 02903, USA, Phone: +401-444-8361, Fax: +401-444-3288

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Wolfsdorf JI, Holm IA, Weinstein DA. Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am 1999;28:801–23.Search in Google Scholar

2. Beauchamp NJ, Dalton A, Ramaswami U, Niinikoski H, Mention K, et al. Glycogen storage disease type IX: High variability in clinical phenotype. Mol Genet Metab 2007;92:88–99.Search in Google Scholar

3. Schimke RN, Zakheim RM, Corder RC, Hug G. Glycogen storage disease type IX: benign glycogenosis of liver and hepatic phosphorylase kinase deficiency. J Pediatr 1973;83:1031–4.Search in Google Scholar

4. Growth Hormone Research S. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000;85:3990–3.Search in Google Scholar

5. Dagdelen S, Atmaca A, Alikasifoglu A, Erbas T. Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report. J Med Case Rep 2008;2:210.Search in Google Scholar

6. Takagi D, Ben-Ari J, Nemet D, Zeharia A, Eliakim A. Recurrent infantile hypoglycemia due to combined fructose-1,6-diphosphatase deficiency and growth hormone deficiency. J Pediatr Endocrinol Metab 2013;26:761–3.Search in Google Scholar

7. Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, et al. The natural history of glycogen storage disease types VI and IX: long-term outcome from the largest metabolic center in Canada. Mol Genet Metab 2014;113:171–6.Search in Google Scholar

8. Stanley CA. Hypoglycemia. In: Radovick S, MacGillivray MH, editors. Contemporary endocrinology: pediatric endocrinology: a practical clinical guide. Totowa, NJ: Humana Press Inc., 2003:511–21.Search in Google Scholar

9. Nunez SB, Municchi G, Barnes KM, Rose SR. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children–a clinical research center study. J Clin Endocrinol Metab 1996;81:1927–32.Search in Google Scholar

10. Larizza D, Maggiore G, Marzani D, Maghnie M, Ciceri R. Difficult hGH treatment in a patient with type III glycogen storage disease. Eur J Pediatr 1986;145:84–5.Search in Google Scholar

11. Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med 2014;16:e1.Search in Google Scholar

12. Brown LM, Corrado MM, van der Ende RM, Derks TG, Chen MA, et al. Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children. J Inherit Metab Dis 2015;38:489–93.Search in Google Scholar

13. Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab 2014;111:309–13.Search in Google Scholar

14. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord 2003;4:95–102.Search in Google Scholar

15. Johnson AO, Goldstein JL, Bali D. Glycogen storage disease type IX: novel PHKA2 missense mutation and cirrhosis. J Pediatr Gastroenterol Nutr 2012;55:90–2.Search in Google Scholar

16. Burwinkel B, Amat L, Gray RG, Matsuo N, Muroya K, et al. Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene. Hum Genet 1998;102:423–9.Search in Google Scholar

17. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502–11.Search in Google Scholar

18. Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med 2016;18:696–704.Search in Google Scholar

19. de Bruin C, Dauber A. Insights from exome sequencing for endocrine disorders. Nature Rev Endocrinol 2015;11:455–64.Search in Google Scholar

Received: 2016-8-29
Accepted: 2016-11-28
Published Online: 2017-1-13
Published in Print: 2017-2-1

©2017 Walter de Gruyter GmbH, Berlin/Boston